HIV Infections Clinical Trials

Completed

Evaluation of the Safety and Tolerance of Immunotherapy With Autologous, Ex-Vivo Expanded, HIV-Specific Cytotoxic T-Cells in HIV-Infected Patients With CD4+ Counts Between 100-400/mm3

NCT00000756

Conditions: AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations: New England Med Ctr / Tufts Univ Boston, Massachusetts, United States

View Trial Details

Completed

A Double-Blind, Placebo-Controlled Trial To Evaluate Intravenous Gamma Globulin in Children With Symptomatic HIV Infection Receiving Zidovudine

NCT00000720

Conditions: AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Bacterial Infections, +17 more
Locations: Kaiser Permanente / UCLA Med Ctr Downey, California, United States

Long Beach Memorial (Pediatric) Long Beach, California, United States

Children's Hosp of Los Angeles/UCLA Med Ctr Los Angeles, California, United States

Los Angeles County - USC Med Ctr Los Angeles, California, United States

View all 51 locations

View Trial Details

Completed

A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC

NCT00000735

Conditions: AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations: George Washington Univ Med Ctr Washington D.C., District of Columbia, United States

Milton S Hershey Med Ctr Hershey, Pennsylvania, United States

View Trial Details

Completed

A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ Cells

NCT00000667

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +14 more
Locations: NY Univ. HIV/AIDS CRS New York, United States

View Trial Details

Completed

A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection

NCT00000762

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach, California, United States

Childrens Hosp. LA - Dept. of Ped., Div. of Clinical Immunology & Allergy Los Angeles, California, United States

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles, California, United States

Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab. Oakland, California, United States

View all 34 locations

View Trial Details

Completed

Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth

NCT00459316

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +14 more
Locations: Usc La Nichd Crs Alhambra, California, United States

Miller Children's Hosp. Long Beach CA NICHD CRS Long Beach, California, United States

Children's Hospital of Los Angeles NICHD CRS Los Angeles, California, United States

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles, California, United States

View all 37 locations

View Trial Details

Completed

A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients

NCT00000947

Conditions: AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Actinomycetales Infections, +28 more
Locations: Community Consortium / Jon Kaiser Wellness Ctr San Francisco, California, United States

Community Consortium / UCSF San Francisco, California, United States

Denver CPCRA / Denver Public Hlth Denver, Colorado, United States

Washington Reg AIDS Prog / Dept of Infect Dis Washington D.C., District of Columbia, United States

View all 19 locations

View Trial Details

Completed

Aerosols in the Treatment of Pneumocystis Pneumonia: A Pilot Study Quantitating the Deposition of Aerosolized Pentamidine as Delivered in ACTG 040 and Comparing Its Toxicity With Parenteral Pentamidine Therapy

NCT00000722

Conditions: AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, +29 more
Locations: SUNY - Stony Brook Stony Brook, New York, United States

View Trial Details

Completed

A Randomized, Unblinded Trial of Zidovudine Versus ddC in the Treatment of Patients Status Post PCP Who Received Long-Term Zidovudine Therapy in Protocol ACTG 002

NCT00000682

Conditions: AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Bacterial Infections and Mycoses, +24 more
Locations: USC CRS Los Angeles, California, United States

Ucsd, Avrc Crs San Diego, California, United States

Univ. of Miami AIDS CRS Miami, Florida, United States

Johns Hopkins Adult AIDS CRS Baltimore, Maryland, United States

View Trial Details

Completed

A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease

NCT00000656

Conditions: Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations: Palo Alto Veterans Adm Med Ctr / Stanford Univ Palo Alto, California, United States

Whitman - Walker Clinic Washington D.C., District of Columbia, United States

Univ of Pittsburgh Pittsburgh, Pennsylvania, United States

Univ of Pittsburgh Med School Pittsburgh, Pennsylvania, United States

View Trial Details

HIV Infections

HIV Infections trial results

Related conditions